Authors


Jimmy Thach, PharmD Candidate

Latest:

Exploring the Benefits, Risks, and Clinical Implications of Herbal Supplements

Examining the clinical applications, effectiveness, safety, and regulation of herbal supplements with a focus on the role of pharmacists.


Leslie Wu

Latest:

Tip of the Week: Staying Ahead of Change to Maintain a Healthy Work Environment

There are a number of ways in which job design and working conditions can be improved in the community pharmacy setting, either on the store level or on an organization-wide basis.


Susan Coultrip, MBA, ACE

Latest:

Five Steps to Ensure Accurate 340B Program Data

Hospitals and health systems proactively monitor and manage data accuracy with third-party administrators to maintain 340B program compliance and maximize benefits for vulnerable patient populations.


Shreya Kumar, PharmD Candidate

Latest:

The Blood Detective: Tackling Medication-Induced Hematological Disorders

These disorders can be fatal, making pharmacists’ role in detection crucial.



Eojin Lee

Latest:

Integrating Pharmacists Into Care Teams Is Crucial

Tapping their specific skill sets and training can help serve patients more effectively, although challenges exist.


Anita N. Jacobson, PharmD

Latest:

The Impact of Xylazine on Overdose Response

Pharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.


Valerie Mondelli

Latest:

Business Solutions Drive Meaningful Results for Pharmacies

As pharmacists provide more health care services, opportunities arise for more sophisticated patient engagement and billing solutions that drive patient satisfaction and increased loyalty.


Caroline Stubbs, PharmD (c), Thy Ton-Morrison PharmD (c), Omar Alkedeh PharmD (c), Jonathan Huynh PharmD (c), Nikhil A. Sangave, PharmD, BCACP

Latest:

Temelimab: A Novel Disease-Modifying Agent for Diabetes Management

Temelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.


Aparna Goel, MD

Latest:

Additional Considerations With PBC Therapies

Panelists discuss how recent FDA regulatory actions regarding obeticholic acid have raised concerns about its long-term safety profile and accessibility, leading health care teams to develop strategies for supporting patients through treatment transitions while navigating insurance coverage and access challenges for newer primary biliary cholangitis (PBC) therapies.



Megan Hinkley, PharmD, MBA, BCOP

Latest:

Empowering Pharmacists in the Management of Patients With Urothelial Cancer

Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients with bladder cancer through treatment selection, patient education, adverse effect monitoring, and the evolving landscape of therapies including traditional chemotherapy, immunotherapy, and antibody-drug conjugates like enfortumab vedotin plus pembrolizumab.


Bhavin Shah, MS

Latest:

Despite Demonstrated Efficacy, The Future of Antiobesity Medications Depends Largely On Supply

Pricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.


Yasmine Baca, MS, PhD candidate, MB(ASCP)CM

Latest:

ASCO 2025: Stratifying NSCLC Treatment by HER2-Alteration Subtype

Nikita Dahake, MD; Hossein Borghaei, DO, MS; and Yasmine Baca, MS, PhD candidate, MB(ASCP)CM, explore how distinct HER2-alteration subtypes in non-small cell lung cancer (NSCLC) impact survival outcomes, co-mutation profiles, and treatment response to immunotherapy-based regimens.


Allison Arant

Latest:

Celebrating Unique Pharmacist Career Paths That Drive Innovation

On the heels of Women Pharmacist Day on October 12, we highlight 3 female pharmacists who have followed unique career paths that help to drive innovation and change in the industry, beyond the retail pharmacy setting.


Nicholas Boemio, PharmD, BCPS

Latest:

Interactive Case Studies: December 2021

How would you respond to these patients' questions?


Dawn Woods, PharmD, DipACLM

Latest:

Lifestyle Medicine Presents Unexpected Opportunity for Pharmacists

Pharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.


Julie Dopheide, PharmD, BCPP, FASHP, FAAPP

Latest:

Building Bridges: Multidisciplinary Care and Patient Education Excellence for TD

Panelists discuss how pharmacists are vital in ensuring personalized care for patients with tardive dyskinesia by fostering continuous, secure communication and collaboration with health care teams across various practice settings.


Austin Cox, PharmD

Latest:

Pharmacists as Advocates: How the MIP Model Supports Access, Adherence, and Outcomes

Medically integrated pharmacies improve collaboration, patient care, communication, and therapy management.


Camille Smith, PharmD, DPLA, CCRP

Latest:

Review of 3 Alternative Pathways to Access Non–FDA-Approved Drugs

Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.


Stephen Eng, PharmD, BCOP

Latest:

New Therapy for Chronic Graft-Vs-Host Disease: Axatilimab

Axatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.


Katherine E. Taylor, PharmD, MBA, BCOP

Latest:

How Pharmacists Can Make an Impact When Treating Dedifferentiated Liposarcoma With Brigimadlin

Brigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.


J. Corey Feist, JD, MBA

Latest:

Breaking Down Barriers to Care and Transforming Pharmacy Professionals’ Mental Health

Pharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.


Sarah Palacio, PharmD, BCPS, BCACP, CPP

Latest:

Pharmacist-Led DOAC Monitoring Improves Dosing

Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.




Bobby Gjorseski, PharmD, RPh

Latest:

Respiratory Syncytial Virus in Older Adults: Research Insights and Recommendations

Although RSV has long been associated with infants and young children, research demonstrates that it is also a significant health risk for adults over the age of 60.


Gabriella Scala

Latest:

Case Studies: May 2022

How would you handle these patients' questions?


Ramzan Judge, PharmD, BCCCP

Latest:

Dispensing Medication for Muslims: A Guide for Pharmacists

Despite Muslim patients’ need for halal medication, more than 80% of pharmacists were found to lack knowledge about where to look to find alternative medications that are halal.


Rachit Thariani

Latest:

Why Data Point to Hospital At-Home Care as Next Evolution of Clinical Medicine

With health systems undergoing a necessary reevaluation of how they allocate their funding into the future, initial data support the need for them to offer a hospital-at-home option for patients they serve.

© 2025 MJH Life Sciences

All rights reserved.